Please login to the form below

Not currently logged in
Email:
Password:

Lothian pharmacies off cessation target

A strategy by NHS Lothian to move much of its smoking cessation services into pharmacies is well behind schedule

A strategy by NHS Lothian - one of the 15 regions of NHS Scotland - to move much of its region's smoking cessation services into pharmacies is well behind schedule on its targets, according to a presentation to the NHS Lothian board members by lead officers Mike Massarro-Mallinson and Fiona Hume.

Massarro-Mallinson and Hume explained that while it had been anticipated that pharmacies would deliver 40 per cent of the target, to date they have only contributed 8 per cent of successful outcomes achieved. 

This is despite a series of measures being outlined to make it happen, such as one-to-one help for quitters who are a month into kicking their habit, a significant advertising campaign signposting that the pharmacy scheme is underway and a pilot scheme which sees city chemists offer impromptu check-ups for harassed commuters.

Following these recent findings, the Lothian health board has vowed to provide extra training to community pharmacy staff in a bid to improve their skills in smoking cessation support and heed NHS Scotland's recent call to local health chiefs to obtain 11,000 successful quitters by 2011.

Despite the poor return from pharmacies however, 44 per cent more people attempted to stop smoking in the Lothians with the help of medics last year than the figures for 2007 reveal.

22nd June 2009

From: Healthcare

Share

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...